Elaine Dunwoodie

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8

Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy

Karl S. Baker, Elaine Dunwoodie, Richard Jones et al. · International Journal of Medical Informatics · 2017 · 97 citations

Engineering, Clinical Decision Support System, Data Science +13

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

Andrew Bottomley, Corneel Coens, Justyna Mierzynska et al. · The Lancet Oncology · 2021 · 70 citations · Full text

Health-related Quality-of-life Results, Surgical Oncology, Oncology +9

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Johnathan Joffe, Fay Cafferty, Laura Murphy et al. · Journal of Clinical Oncology · 2022 · 57 citations · Full text

Survival patterns in teenagers and young adults with cancer in the United Kingdom: Comparisons with younger and older age groups

Dan Stark, David Bowen, Elaine Dunwoodie et al. · European Journal of Cancer · 2015 · 33 citations

Young Adults, Cancer Epidemiology, Medicine +8